These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 26099340)
1. Brachyury: A sensitive marker, but not a prognostic factor, for skull base chordomas. Wang K; Tian K; Wang L; Wu Z; Ren C; Hao S; Feng J; Li J; Wan H; Jia G; Zhang L; Zhang J Mol Med Rep; 2015 Sep; 12(3):4298-4304. PubMed ID: 26099340 [TBL] [Abstract][Full Text] [Related]
2. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases. Jambhekar NA; Rekhi B; Thorat K; Dikshit R; Agrawal M; Puri A Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140 [TBL] [Abstract][Full Text] [Related]
3. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis. Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741 [TBL] [Abstract][Full Text] [Related]
4. Chordoma: Immunohistochemical Analysis of Brachury. Sun HI; Guduk M; Gucyetmez B; Yapicier O; Pamir MN Turk Neurosurg; 2018; 28(2):174-178. PubMed ID: 28094431 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma. Morimoto Y; Tamura R; Ohara K; Kosugi K; Oishi Y; Kuranari Y; Yoshida K; Toda M J Neurooncol; 2019 Aug; 144(1):65-77. PubMed ID: 31240525 [TBL] [Abstract][Full Text] [Related]
6. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma. Otani R; Mukasa A; Shin M; Omata M; Takayanagi S; Tanaka S; Ueki K; Saito N J Neurosurg; 2018 May; 128(5):1428-1437. PubMed ID: 28753115 [TBL] [Abstract][Full Text] [Related]
7. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis. Oakley GJ; Fuhrer K; Seethala RR Mod Pathol; 2008 Dec; 21(12):1461-9. PubMed ID: 18820665 [TBL] [Abstract][Full Text] [Related]
8. T gene isoform expression pattern is significantly different between chordomas and notochords. Wang K; Hu Q; Wang L; Chen W; Tian K; Cao C; Wu Z; Jia G; Zhang L; Zeng C; Zhang J Biochem Biophys Res Commun; 2015 Nov; 467(2):261-7. PubMed ID: 26435504 [TBL] [Abstract][Full Text] [Related]
9. Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma. Zhang L; Guo S; Schwab JH; Nielsen GP; Choy E; Ye S; Zhang Z; Mankin H; Hornicek FJ; Duan Z PLoS One; 2013; 8(9):e75851. PubMed ID: 24086644 [TBL] [Abstract][Full Text] [Related]
10. C-Cbl and Cbl-b expression in skull base chordomas is associated with tumor progression and poor prognosis. Luo P; Wang X; Zhou J; Li L; Jing Z Hum Pathol; 2018 Apr; 74():129-134. PubMed ID: 29317233 [TBL] [Abstract][Full Text] [Related]
11. Patterns of brachyury expression in chordomas. Dridi M; Boutonnat J; Dumollard JM; Peoc'h M; Karpathiou G Ann Diagn Pathol; 2021 Aug; 53():151760. PubMed ID: 33989961 [TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological features of intradural retroclival chordoma. Wang L; Wu Z; Tian K; Li G; Zhang J World Neurosurg; 2014 Nov; 82(5):791-8. PubMed ID: 23416632 [TBL] [Abstract][Full Text] [Related]
13. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis. Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of the BMP4/SMAD signaling pathway in skull base chordomas is associated with poor prognosis. Feng Y; Zhang Q; Wang Z; Yan B; Wei W; Li P Int J Clin Exp Pathol; 2015; 8(7):8268-75. PubMed ID: 26339396 [TBL] [Abstract][Full Text] [Related]
15. High expression of survivin independently correlates with tumor progression and mortality in patients with skull base chordomas. Ma J; Tian K; Du J; Wu Z; Wang L; Zhang J J Neurosurg; 2020 Jan; 132(1):140-149. PubMed ID: 30641849 [TBL] [Abstract][Full Text] [Related]
17. Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation. O'donnell P; Tirabosco R; Vujovic S; Bartlett W; Briggs TW; Henderson S; Boshoff C; Flanagan AM Skeletal Radiol; 2007 Jan; 36(1):59-65. PubMed ID: 16810540 [TBL] [Abstract][Full Text] [Related]
18. Predictive Value of Transforming Growth Factor-α and Ki-67 for the Prognosis of Skull Base Chordoma. Zhang S; Bai J; Li M; Zhai Y; Wang S; Liu Q; Li C; Gui S; Zhang Y World Neurosurg; 2019 Sep; 129():e199-e206. PubMed ID: 31125781 [TBL] [Abstract][Full Text] [Related]
19. SNF5 as a prognostic factor in skull base chordoma. Li M; Zhai Y; Bai J; Wang S; Gao H; Li C; Gui S; Du J; Zhang Y J Neurooncol; 2018 Mar; 137(1):139-146. PubMed ID: 29222701 [TBL] [Abstract][Full Text] [Related]
20. Expression of ezrin, MMP-9, and COX-2 in 50 chordoma specimens: a clinical and immunohistochemical analysis. Froehlich EV; Scheipl S; Lazàry A; Varga PP; Schmid C; Stammberger H; Beham A; Bodo K; Schroettner H; Quehenberger F; Windhager R; Liegl B; Leithner A Spine (Phila Pa 1976); 2012 Jun; 37(13):E757-67. PubMed ID: 22228328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]